Alterity Therapeutics ATHE
NASDAQ ATHE
$2.39 -0.04 (-1.65%)
At close: Oct 21, 2026 · 4:00 PM EDT

Alterity Therapeutics (ATHE) Interest Expenses (2013)

Updated

Alterity Therapeutics' Interest Expenses was -$55,052 in the year ended Jun 30, 2014, compared with -$36,315 a year earlier.

Analysis

Alterity Therapeutics (ATHE) Interest Expenses (2013) Analysis & Trends

From the year ended Jun 30, 2011 onward, Alterity Therapeutics has reported Interest Expenses for 4 years.

  • Per Business Quant data, Interest Expenses in earlier years was -$36,315 in the year ended Jun 30, 2013, -$11,666 in the year ended Jun 30, 2012 and -$3,990 in the year ended Jun 30, 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 281.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 435.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 247.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Alterity Therapeutics 41.90 Mn -41.25 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 12,522.13
API Access

Alterity Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=ATHE&period=max&api_key=YOUR_API_KEY